Opening stock page...
Fetching company snapshot, pricing, and intelligence.
AI confidence 89% · prior close shown (market closed)
Beta Bionics, Inc. shows accelerating business momentum based on AlphaOS pipeline evidence, with mixed management execution.
Why it matters: Revenue +38% YoY in Q2 FY2026.
What it means for the thesis — synthesis, not a raw event feed.
Pipeline evidence · 21d ago
BBNX's AlphaOS Signals
Upgrade to Pro for validated historical pattern analysis on BBNX.
Free accounts see more of this; Premium sees all of it.
Reported figures for Beta Bionics, Inc. — research only, not investment advice.
Updated
What happened recently for Beta Bionics, Inc. (BBNX) — events, not interpretation.
Research & analysis only — not investment advice.
Held in ETFsweight · est. sleeve dollars
Investment snapshot
BBNX's AI investment thesis
Upgrade to Premium for BBNX's full multi-agent investment thesis.
Free accounts see more of this; Premium sees all of it.
Unified data coverage and cross-signal highlights — market, SEC, earnings, opportunity
Strengthen intelligence
Prior close
$21.51
Market cap
$967.73M
Profitable
No
Revenue $32.01M
Net income
$-23.40M
FY Sep 1, 2026
Loading Wall Street consensus…
Loading earnings intelligence…
Building technical intelligence snapshot — check back shortly.
Loading market context…
No price history. Sync market data to load charts.
Loading SEC filing intelligence…
No filings ingested yet.
Investment Snapshot above is the primary AlphaOS analysis for Beta Bionics, Inc. — structured signals and evidence from proprietary pipelines, not an encyclopedia overview.
Research & analysis only — not investment advice. Price, charts, and filings are above.
Follow Beta Bionics, Inc. through AlphaOS's knowledge graph — themes, peers, beneficiaries, earnings, and research answers.
Connected companies and research pages from the AlphaOS knowledge graph.